<DOC>
	<DOCNO>NCT00993941</DOCNO>
	<brief_summary>The objective study evaluate therapeutic efficacy autologous bone marrow mesenchymal stem cell ( BMSCs ) transplantation via portal vein patient early middle stage liver cirrhosis basis HBV infection . The evaluation efficacy include level serum alanine aminotransferase ( ALT ) , aspartate aminotransferase ( AST ) , total bilirubin ( TB ) , prothrombin time ( PT ) , albumin ( ALB ) , prealbumin ( PA ) , precollagenⅢ ( PCⅢ ) , collagenⅣ ( Ⅳ-C ) , laminin ( LN ) , hyaluronidase ( HN ) , liver histological improvement 1 week 1 year transplantation . Child-Pugh score clinical symptom also observe simultaneously .</brief_summary>
	<brief_title>Bone Mesenchymal Stem Cell ( BMSC ) Transplantation Liver Cirrhosis Via Portal Vein</brief_title>
	<detailed_description />
	<mesh_term>Fibrosis</mesh_term>
	<mesh_term>Liver Cirrhosis</mesh_term>
	<criteria>Aged 18~60 year . Serum HBsAg positive . Ultrasonographic evidence cirrhosis . history moderate severe hepatic encephalopathy variceal bleed last two month enrolment . Prothrombin time less 30 . Cirrhosis cause reason except HBV infection . Severe problem vital organ ( e.g.the heart , renal lung ) . Liver tumor ultrasonography , CT MRI examination . Pregnant lactating woman . Imaging evidence vascular thromboses .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>October 2009</verification_date>
	<keyword>BMSC</keyword>
	<keyword>Stem cell</keyword>
	<keyword>Liver cirrhosis</keyword>
	<keyword>Transplantation</keyword>
</DOC>